GGrantIndex
Sort

64,565 grants matching drug discovery

Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy

$768,551
Jonathan Harvey Soslow · Vanderbilt University Medical Center · R56 · FY2018 · HL

Carbohydrate-based Therapy for Lung Disease

$768,543
John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

$768,540
Issam A Awad · University Of Chicago · R01 · FY2021 · NS

Core--Development and analysis of SOD/Catalase mimetics

$768,513
Susan Doctrow · Medical College Of Wisconsin · U19 · FY2008 · AI

Growth Factor Imaging

$768,482
Peter L. Choyke · Basic Sciences · Z01 · FY2007 · CA

Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease

$768,451
Mark W Albers · Massachusetts General Hospital · R01 · FY2019 · AG

Screening for Inhibitors of the Chromatin Reader SGF29

$768,437
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

University of Michigan Proteogenomics Data Analysis Center

$768,426
Alexey I Nesvizhskii · University Of Michigan At Ann Arbor · U24 · FY2020 · CA

Novel Antithrombotic Diadenosine Tetraphosphate Analogs

$768,369
Ivan B Yanachkov · Glsynthesis, Inc. · R44 · FY2009 · HL

Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease

$768,267
Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG

Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth

$768,194
Kristina M Adams Waldorf · University Of Washington · R01 · FY2023 · HD

Mechanisms of Prion Protein Toxicity

$768,128
David A Harris · Boston University Medical Campus · R01 · FY2025 · NS

Pharmacogenomics of HIV Therapy

$768,079
David W Haas · Vanderbilt University · R01 · FY2012 · AI

Porcine Related apprOach to Multidisciplinary cOllaborative Translational ModEl Research (PROMOTER)

$768,064
Evan Samuel Dellon · Univ Of North Carolina Chapel Hill · RC2 · FY2025 · TR

Using genetic variation to study biology of blood lipids & coronary heart disease

$767,997
Cristen J Willer · University Of Michigan At Ann Arbor · R01 · FY2018 · HL

New antifungals targeting the synthesis of fungal sphingolipids

$767,822
Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2023 · AI

Core 3: Drug Discovery and Development Core

$767,793
Mark J Suto · University Of Alabama At Birmingham · U54 · FY2020 · ES

Development and Validation of Animal Models and/or Outcome Measures

$767,756
Gregory Scherrer · Univ Of North Carolina Chapel Hill · U19 · FY2024 · NS

Ligand discovery for delineating cholesterol homeostasis in the brain

$767,614
Steven H Liang · Emory University · R01 · FY2024 · AG

Linking antibody sequences to function at the single-cell level using nanovial technology

$767,559
Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2023 · GM

Leveraging Integrative Modeling and AI-Based Tools to Develop Safer Opioids

$767,506
Marta Filizola · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA

Anastasis, a new mechanism driving cell survival and evolution

$767,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2015 · CA

Anastasis, a new mechanism driving cell survival and evolution

$767,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2016 · CA

Anastasis, a new mechanism driving cell survival and evolution

$767,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2018 · CA

Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease

$767,500
Rebekah L. Gundry · University Of Nebraska Medical Center · R35 · FY2025 · HL